Assignee
BAXALTA INC
US89 patents
Top patents by PatentIndex Score
US11020458B2Jun 1, 2021
Factor VIII polymer conjugates
BAXALTA INC9 citations94
US9714411B2Jul 25, 2017
Animal protein-free media for cultivation of cells
BAXALTA INC16 citations93
US9409971B2Aug 9, 2016
Method of producing recombinant high molecular weight vWF in cell culture
BAXALTA INC15 citations93
US10758599B2Sep 1, 2020
Stabilized liquid and lyophilized ADAMTS13 formulations
BAXALTA INC10 citations92
US9809796B2Nov 7, 2017
Animal protein-free media for cultivation of cells
BAXALTA INC13 citations90
USD788937SJun 6, 2017
Packaging unit for single medical device
BAXALTA INC22 citations88
USD788936SJun 6, 2017
Packaging unit for single medical device
BAXALTA INC26 citations88
US11020459B2Jun 1, 2021
Factor VIII formulations
BAXALTA INC9 citations84
US9758568B2Sep 12, 2017
Oligopeptide-free cell culture media
BAXALTA INC10 citations84
US9731024B2Aug 15, 2017
Nucleophilic catalysts for oxime linkage
BAXALTA INC9 citations84
US9708391B2Jul 18, 2017
Removal of serine proteases by treatment with finely divided silicon dioxide
BAXALTA INC3 citations84
US9468675B2Oct 18, 2016
Removal of serine proteases by treatment with finely divided silicon dioxide
BAXALTA INC4 citations84
US11197916B2Dec 14, 2021
Lyophilized recombinant VWF formulations
BAXALTA INC9 citations83
US10238720B2Mar 26, 2019
Stabilized liquid and lyophilized ADAMTS13 formulations
BAXALTA INC5 citations83
US10209263B2Feb 19, 2019
Methods of measuring adamts 13 activity
BAXALTA INC5 citations83
US10072254B2Sep 11, 2018
Cell culture methods for expressing ADAMTS13 protein
BAXALTA INC3 citations83
US9937244B2Apr 10, 2018
Stabilized liquid and lyophilized ADAMTS13 formulations
BAXALTA INC4 citations83
US9669076B2Jun 6, 2017
Albumin-free factor VIII formulations
BAXALTA INC4 citations83
US9572778B2Feb 21, 2017
Stabilized liquid and lyophilized ADAMTS13 formulations
BAXALTA INC4 citations83
US9492555B2Nov 15, 2016
Nucleophilic catalysts for oxime linkage
BAXALTA INC7 citations83
US9488651B2Nov 8, 2016
Methods of measuring ADAMTS 13 activity
BAXALTA INC3 citations83
US9441216B2Sep 13, 2016
Cell culture medium for ADAMTS protein expression
BAXALTA INC5 citations83
US10738107B2Aug 11, 2020
Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural iggs
BAXALTA INC4 citations82
US10414793B2Sep 17, 2019
Nucleophilic catalysts for oxime linkage
BAXALTA INC4 citations82
US10125189B2Nov 13, 2018
Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
BAXALTA INC7 citations82
US10232022B2Mar 19, 2019
Lyophilized recombinant VWF formulations
BAXALTA INC9 citations81
US10189888B2Jan 29, 2019
Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A
BAXALTA INC6 citations81
US9556260B2Jan 31, 2017
Treatment of central nervous system disorders by intranasal administration of immunoglobulin G
BAXALTA INC4 citations80
US9512198B2Dec 6, 2016
FVIII peptides for immune tolerance induction and immunodiagnostics
BAXALTA INC5 citations80
US11081211B2Aug 3, 2021
Method and apparatus for providing a pharmacokinetic drug dosing regimen
BAXALTA INC9 citations77
US10822376B2Nov 3, 2020
Biologically active peptides
BAXALTA INC1 citations73
US10723761B2Jul 28, 2020
Protein purification by anion exchange chromatography
BAXALTA INC2 citations73
US10576160B2Mar 3, 2020
Nucleophilic catalysts for oxime linkage
BAXALTA INC3 citations73
US10350301B2Jul 16, 2019
Blood coagulation protein conjugates
BAXALTA INC4 citations73
US10138461B2Nov 27, 2018
Animal protein-free media for cultivation of cells
BAXALTA INC2 citations73
US10724024B2Jul 28, 2020
Cell culture methods for expressing ADAMTS protein
BAXALTA INC1 citations72
US9732327B2Aug 15, 2017
Formulation of sugar solutions for continuous ultracentrifugation for virus purification
BAXALTA INC2 citations72
US9782477B2Oct 10, 2017
Fraction I-IV-1 precipitation of immunoglobins from plasma
BAXALTA INC3 citations71
US9556261B2Jan 31, 2017
Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGs
BAXALTA INC3 citations71
US10842853B2Nov 24, 2020
Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia B
BAXALTA INC2 citations70
US10189889B2Jan 29, 2019
Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A
BAXALTA INC2 citations70
US10527551B2Jan 7, 2020
Method of predicting a performance characteristic of a plant or yeast hydrolysate and its use
BAXALTA INC2 citations69
US10494418B2Dec 3, 2019
IgG stimulated remyelination of peripheral nerves
BAXALTA INC1 citations69
US9895434B2Feb 20, 2018
Chimeric OspA genes, proteins and methods of use thereof
BAXALTA INC2 citations69
US10905746B2Feb 2, 2021
Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF
BAXALTA INC2 citations68
US10632176B2Apr 28, 2020
Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF
BAXALTA INC3 citations68
US9505814B2Nov 29, 2016
Manufacture of inter-alpha-inhibitor (IaIp) from plasma
BAXALTA INC4 citations68
US9873892B2Jan 23, 2018
Production of fully processed and functional factor X in a furin-secreting mammalian expression system
BAXALTA INC2 citations66
US11040109B2Jun 22, 2021
Blood coagulation protein conjugates
BAXALTA INC1 citations62
US10934340B2Mar 2, 2021
Separation of VWF and VWF propeptide by chromatographic methods
BAXALTA INC0 citations61
Showing the top 50 of 89 patents by PatentIndex Score.